Application for approval for adults unable to consent to their own treatment to participate in a clinical trial (SPICE III Trial) [2014] NSWCATGD 44
The Tribunal found the SPICE III trial constitutes a clinical trial within the Guardianship Act 1987 (NSW), as it tests a hypothesis by randomising patients between two sedation strategies, including use of dexmedetomidine beyond its TGA licence, and necessarily involves medical treatment. The trial satisfies all statutory criteria in section 45AA(2), including evidence of ethical approval, safety, and best interests. As consent forms relied on 'delayed consent', which the Guardianship Act does not permit, the Tribunal determined it must exercise the function of giving or withholding consent for individual patients.
- Jurisdiction
- Australia
- Judgment Date
- 23 December 2014
- Procedural Posture
- Application for Approval for Adults Unable to Consent to Their Own Treatment to Participate in a Clinical Trial / Final Determination and Orders
- Outcome
- Approved
- Legal Topics
- ['clinical Trials' 'consent for Medical Treatment' 'guardianship Act Criteria' 'therapeutic Goods Administration' 'ethics Approval']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Application for Approval for Adults Unable to Consent to Their Own Treatment to Participate in a Clinical Trial / Final Determination and Orders
Legal Issues
- 1 ["Is the SPICE III clinical trial a 'clinical trial' within the meaning of the Guardianship Act 1987 (NSW)?" 'Does the trial meet statutory criteria for Tribunal approval under section 45AA(2) of the Guardianship Act?' 'Should consent to participation for adults lacking capacity be provided by the Tribunal or a person responsible?']
Ratio Decidendi
The Tribunal found the SPICE III trial constitutes a clinical trial within the Guardianship Act 1987 (NSW), as it tests a hypothesis by randomising patients between two sedation strategies, including use of dexmedetomidine beyond its TGA licence, and necessarily involves medical treatment. The trial satisfies all statutory criteria in section 45AA(2), including evidence of ethical approval, safety, and best interests. As consent forms relied on 'delayed consent', which the Guardianship Act does not permit, the Tribunal determined it must exercise the function of giving or withholding consent for individual patients.
Court Disposition
Approved
Orders
- ['The SPICE III Trial is approved as a clinical trial in which adults who are unable to consent may participate.' 'The function of giving or withholding consent to participation for individual patients shall be exercised by the Tribunal.']
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment